MRI findings of myocardial deformation for the differential diagnosis of non-obstructive hypertrophic cardiomyopathy and left ventricular hypertrophy in hypertension: a retrospective study
Digital Diagnostics · 2026-09-01 · 7 (3) · 285-295
DOI: 10.17816/dd692431 ↗Abstract
BACKGROUND: Differential diagnosis of diseases associated with left ventricular hypertrophy remains clinically challenging. Assessment of myocardial strain using non-contrast cardiovascular magnetic resonance imaging may help distinguish non-obstructive hypertrophic cardiomyopathy from left ventricular hypertrophy secondary to arterial hypertension. Validated diagnostic criteria and threshold values for accurately differentiating hypertrophic cardiomyopathy from left ventricular hypertrophy secondary to arterial hypertension are currently lacking, highlighting the need for further research. AIM: To evaluate the diagnostic value of cardiovascular magnetic resonance imaging markers of left ventricular myocardial strain in differentiating non-obstructive hypertrophic cardiomyopathy from left ventricular hypertrophy secondary to arterial hypertension. METHODS: This retrospective, single-center, case-control study included adult patients with non-obstructive hypertrophic cardiomyopathy and left ventricular hypertrophy secondary to arterial hypertension. Myocardial strain parameters were assessed using Feature Tracking cine cardiovascular magnetic resonance imaging with electrocardiographic gating. The following parameters were evaluated as potential predictors of hypertrophic cardiomyopathy or left ventricular hypertrophy: global radial, circumferential, and longitudinal myocardial strain parameters measured in 2-dimensional and 3-dimensional modes, together with standard left ventricular morphometric parameters. Our diagnostic model utilized statistical assessment of diagnostic performance, including receiver operating characteristic curve analysis. RESULTS: The study included 29 patients with non-obstructive hypertrophic cardiomyopathy (mean age, 53 ± 13.2 years; 72% male) and 32 patients with left ventricular hypertrophy (mean age, 57 ± 13.4 years; 44% male). Global longitudinal strain was identified as an independent predictor of the diagnostic outcome. In 2-dimensional mode, global longitudinal strain was −10.24 ± 5.19% in hypertrophic cardiomyopathy and −13.20 ± 2.70% in left ventricular hypertrophy (p = 0.008). In 3-dimensional mode, the corresponding values were −8.66 ± 3.16% and −10.19 ± 4.35%, respectively (p = 0.043). The optimal threshold for global longitudinal strain was −11.08% in 2-dimensional mode (sensitivity,0.90; specificity, 0.51), and −8.19% in 3-dimensional mode (sensitivity, 0.84; specificity, 0.51). CONCLUSION: Using the Feature Tracking analysis on non-contrast cardiovascular magnetic resonance images for myocardial strain evaluation yields diagnostically relevant global longitudinal strain thresholds in both 2-dimensional and 3-dimensional modes. These parameters help differentiating non-obstructive hypertrophic cardiomyopathy from left ventricular hypertrophy secondary to arterial hypertension.
EUVIMED